IsoPlexis (ISO) Financials

$0.76

$0.00 (0.00%)

As on 27-Mar-2023 09:30EDT

Market cap

$30 Mln

Revenue (TTM)

$17 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	16.76	0.02	10.39	7.51	--	--
Cost of Revenue	17.69	0.01	4.97	3.26	--	--
Gross Profit	-0.93	0.01	5.41	4.25	--	--
Operating Expenses	95.57	85.09	28.57	17.86	--	--
Operating Profit (EBIT)	-96.49	-76.32	-23.16	-13.62	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-106.00	-0.08	-23.26	-13.63	--	--
Provision for Tax	9.51	-76.24	0.09	0.01	--	--
Profit after Tax (Net Income)	-115.50	76.16	-23.35	-13.64	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-92.02	-25.24	-15.11	--	--

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	41.27	0.14	92.21	35.05	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	50.09	0.03	26.77	0.12	--	--
Current Liabilities	17.71	0.01	4.62	2.71	--	--
Total Liabilities	109.07	0.19	123.61	37.89	--	--

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	37.20	0.03	7.93	4.02	--	--
Current Assets	71.87	0.16	115.67	33.87	--	--
Total Assets	109.07	0.19	123.61	37.89	--	--
Total Debt*	51.68	0.03	22.14	--	--	--
Net Current Assets	54.15	144.86	111.05	31.16	--	--

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-96.64	-86.51	-22.43	-14.96	--	--
Cash Flow from Investing Activities	--	-24.22	-2.30	-2.18	--	--
Cash from Financing Activities	15.33	130.66	104.00	22.48	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-2.96	7.62	--	--	--	--
Cash EPS ($)	-2.83	7.85	--	--	--	--
Adjusted Book Value ($)	1.06	0.01	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-2.48	-8.65	--	--	--	--
Free Cash Flow per Share ($)	-2.68	-9.03	--	--	--	--

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-248.08	133.01	-31.26	--	--	--
ROE (%)	-557.86	164.94	-36.70	--	--	--
ROA (%)	-211.44	123.04	-28.92	--	--	--
EBIT Margin (%)	-575.69	-442,247.07	-222.98	-181.41	--	--
Net Margin (%)	-689.12	441,301.78	-224.79	-181.69	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	970.20	-1.00	0.38	--	--	--
EBIT Growth (%)	-26.42	-229.53	-70.11	--	--	--
Net Profit Growth (%)	-251.66	426.18	-71.23	--	--	--
EPS Growth (%)	-1.39	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-0.52	1.21	--	--	--	--
Price / Book Value	1.46	646.07	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.78	41.32	--	--	--	--
Close Price ($)	1.55	9.19	--	--	--	--
High Price ($)	10.13	16.95	--	--	--	--
Low Price ($)	0.60	4.77	--	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	1.25	0.22	0.24	--	--	--
Short term debt to equity ratio	0.04	--	--	--	--	--
Current Ratio	4.06	11.67	25.03	12.48	--	--
Quick Ratio	2.50	9.88	24.17	11.30	--	--
Interest Coverage	-18.06	-21,095.36	-1,102.90	-13,615.00	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	26.86	23,757.10	28.13	37.92	--	--
Asset Turnover	0.31	0.00	0.13	--	--	--
Receivable days	93.73	74,307.15	101.41	138.51	--	--
Inventory Days	284.38	85,576.95	262.45	357.96	--	--
Payable days	28.78	46,061.39	132.73	165.70	--	--
Cash Conversion Cycle	349.33	113,822.71	231.13	330.77	--	--